Fulminant Hepatic Failure clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
TReatment for ImmUne Mediated PathopHysiology
Sorry, not currently recruiting here
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.
at UCSF
Last updated: